Julio A. Camarero leads work on ultrastable macrocyclic peptides to modulate protein-protein interactions. He holds two issued patents, an ACS Discovery Boost Award, and >$4M in competitive funding, advancing in-cell screening platforms, imaging reagents, and preclinical anti-infective and anticancer leads.